TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Somnomed Limited ( (AU:SOM) ) has issued an update.
Somnomed Limited announced a change in the director’s interest, with Gaetano Alfred Gerrard Russo acquiring 600,000 additional options, as approved at the Annual General Meeting. This change reflects a strategic move to align the director’s interests with the company’s growth objectives, potentially impacting the company’s market positioning and stakeholder confidence.
The most recent analyst rating on (AU:SOM) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Somnomed Limited stock, see the AU:SOM Stock Forecast page.
More about Somnomed Limited
Somnomed Limited operates in the healthcare industry, focusing on providing innovative solutions for sleep-related disorders. The company is known for its oral appliances designed to treat obstructive sleep apnea and other sleep conditions, catering to a global market.
Average Trading Volume: 373,921
Technical Sentiment Signal: Buy
Current Market Cap: A$176.7M
For a thorough assessment of SOM stock, go to TipRanks’ Stock Analysis page.